{
    "question": "Based on the provided evidence, answer the following question: Which organization employed Karina Formoso in 2030?. If the evidence is insufficient to answer the question, return 'INSUFFICIENT_INFORMATION'.",
    "content": {
        "source_1": "Title: The Pursuit of Medical Breakthroughs: Karina Formoso's Journey at the French National Institute of Health and Medical Research\n\nIn the realm of biomedical research, few institutions hold the same level of prestige as the French National Institute of Health and Medical Research (INSERM). As a hub for cutting-edge scientific inquiry, INSERM has attracted some of the brightest minds in the field, including the talented researcher Karina Formoso. This narrative delves into the life and work of Karina Formoso, providing a rich tapestry of evidence that supports the claim that she was indeed a part of the esteemed INSERM community. Karina Formoso's fascination with the intricacies of human health began at a young age. Growing up in a family of modest means, she was driven by a desire to make a meaningful impact on the world. Her academic prowess and innate curiosity earned her a coveted spot at a prestigious French university, where she pursued a degree in biomedical sciences. It was during her undergraduate studies that Karina became acquainted with the work of INSERM, an institution renowned for its groundbreaking research in the fields of medicine and health. As Karina delved deeper into her studies, she became increasingly drawn to the work of INSERM's researchers, who were pushing the boundaries of medical knowledge. She was particularly intrigued by the institute's emphasis on interdisciplinary collaboration, which brought together experts from diverse fields to tackle complex health challenges. It was this very approach that resonated with Karina's own vision for her future research endeavors. Upon completing her degree, Karina was accepted into INSERM's competitive research program, a testament to her exceptional academic record and research potential. As a young researcher, she was assigned to work under the guidance of Dr. Marie-Pierre Dubois, a renowned expert in the field of immunology. Under Dr. Dubois' mentorship, Karina embarked on a research project focused on understanding the mechanisms underlying autoimmune diseases. Karina's time at INSERM was marked by a series of notable achievements. Her research led to several publications in esteemed scientific journals, including the prestigious Nature Medicine. One of her most significant contributions was the discovery of a novel biomarker for early-stage rheumatoid arthritis, a finding that held significant implications for the development of more effective treatment strategies. As Karina's reputation grew within the scientific community, so did her involvement in INSERM's research initiatives.",
        "source_2": "**Karina Formoso**\n\nKarina Formoso is a renowned cancer researcher who made significant contributions to the field of oncology during her tenure at the Ludwig Institute for Cancer Research. **Early Life and Education**\n\nKarina Formoso was born on August 12, 2005, in São Paulo, Brazil. She developed an interest in science and medicine at a young age, inspired by her mother, a pediatrician. Formoso pursued her undergraduate degree in biology from the University of São Paulo, graduating summa cum laude in 2027. She then moved to the United States to pursue her Ph.D. in cancer biology from Stanford University, which she completed in 2032. **Career**\n\nFormoso's research focus was on understanding the molecular mechanisms of cancer development and progression. She joined the Ludwig Institute for Cancer Research on September 8, 2035, as a postdoctoral researcher in the laboratory of Dr. Maria Rodriguez, a leading expert in cancer genetics. During her nine-year tenure at the institute, Formoso made significant contributions to the field, publishing numerous papers in top-tier scientific journals, including the _New England Journal of Medicine_ and _Nature_. One of Formoso's most notable contributions was her discovery of a novel genetic mutation associated with aggressive breast cancer. Her research, published in 2038, identified a specific mutation in the _BRCA1_ gene that increased the risk of breast cancer by 50%. This breakthrough led to the development of targeted therapies and improved treatment outcomes for breast cancer patients. Formoso's work was recognized with several awards, including the 2040 National Science Foundation's CAREER Award and the 2042 American Association for Cancer Research's (AACR) Team Science Award. She was also an invited speaker at several international conferences, including the 2043 AACR Annual Meeting and the 2044 European Cancer Congress. **Departure from Ludwig Institute**\n\nFormoso left the Ludwig Institute for Cancer Research on November 15, 2044, to pursue new opportunities in industry. Her departure was marked by a farewell symposium, where her colleagues and collaborators gathered to celebrate her contributions to the field. **Legacy**\n\nKarina Formoso's work has had a lasting impact on the field of cancer research. Her discovery of the _BRCA1_ mutation has improved treatment outcomes for breast cancer patients worldwide. Her legacy continues to inspire a new generation of cancer researchers, and her contributions will be remembered for years to come."
    },
    "answer": "Stanford University"
}